Triptorelin pamoate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triptorelin pamoate and what is the scope of patent protection?
Triptorelin pamoate
is the generic ingredient in two branded drugs marketed by Azurity and Verity, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Triptorelin pamoate has forty-six patent family members in thirty-one countries.
There are two drug master file entries for triptorelin pamoate. Two suppliers are listed for this compound.
Summary for triptorelin pamoate
International Patents: | 46 |
US Patents: | 1 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 4 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 56 |
Clinical Trials: | 17 |
Patent Applications: | 6,823 |
What excipients (inactive ingredients) are in triptorelin pamoate? | triptorelin pamoate excipients list |
DailyMed Link: | triptorelin pamoate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for triptorelin pamoate
Generic Entry Dates for triptorelin pamoate*:
Constraining patent/regulatory exclusivity:
TREATMENT OF PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER WITH CENTRAL PRECOCIOUS PUBERTY Dosage:
FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
Generic Entry Dates for triptorelin pamoate*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INTRAMUSCULAR |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for triptorelin pamoate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cancer Research Antwerp | Phase 2 |
Janssen Pharmaceutica | Phase 2 |
National Cancer Institute (NCI) | Phase 1/Phase 2 |
Medical Subject Heading (MeSH) Categories for triptorelin pamoate
US Patents and Regulatory Information for triptorelin pamoate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 022437-001 | Mar 10, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Azurity | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Azurity | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for triptorelin pamoate
International Patents for triptorelin pamoate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1118434 | ⤷ Try a Trial | |
China | 101677959 | Slow release pharmaceutical composition made of microparticles | ⤷ Try a Trial |
Denmark | 2164467 | ⤷ Try a Trial | |
European Patent Office | 2164467 | COMPOSITION PHARMACEUTIQUE À LIBÉRATION LENTE, FAITE DE MICROPARTICULES (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES) | ⤷ Try a Trial |
Israel | 202501 | תכשירים המכילים מיקרו חלקיקים לשחרור מבוקר של טריפטולרין ושימוש בהם להכנת תרופה לטיפול בסרטן הערמונית (Pharmaceutical composition made of microparticles for controlled release of triptorelin and use thereof for the manufacture of a drug for the treatment of prostate cancer) | ⤷ Try a Trial |
Denmark | 2500014 | ⤷ Try a Trial | |
European Patent Office | 3431077 | COMPOSITION PHARMACEUTIQUE À LIBÉRATION LENTE FABRIQUÉE À PARTIR DE MICROPARTICULES (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |